A study to compare liposomal iron with ferrous ascorbate in treatment of iron deficiency anaemia in childre
- Conditions
- Health Condition 1: D508- Other iron deficiency anemias
- Registration Number
- CTRI/2023/08/056246
- Lead Sponsor
- amita Mishra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Children in the age group 6 to 59 months with Iron Deficiency Anaemia as confirmed by hematological parameters
1. Subjects with other causes of anemia(hemolytic anemia, bone marrow failure) as evidenced by
clinical symptoms and signs and or laboratory values
2. Subjects with ongoing blood loss
3. Subjects who have received any iron therapy or blood transfusion in the past 3 months
4. Subjects with disease interfering with iron absorption e.g. Inflammatory bowel disease, celiac
disease, bowel surgery, chronic gastrointestinal infection
5. Subjects with serious chronic medical conditions like chronic kidney disease, congenital heart disease, and chronic lung disease.
6. Subjects with prior history of allergy to iron preparations
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rise in hemoglobin levels from baseline in gram per deciliterTimepoint: 0, 4 and 12 weeks
- Secondary Outcome Measures
Name Time Method Adherence to medicine in both groups as measured by volume of unused drug brought in follow up visit.Timepoint: 0, 4 and 12 weeks;Change in mean corpuscular volume, corrected reticulocyte count, serum iron, serum ferritin, total iron binding capacity and transferrin saturation from baselineTimepoint: 0, 4 and 12 weeks